188 related articles for article (PubMed ID: 29854292)
1. Somatic mutations in early onset luminal breast cancer.
Encinas G; Sabelnykova VY; de Lyra EC; Hirata Katayama ML; Maistro S; de Vasconcellos Valle PWM; de Lima Pereira GF; Rodrigues LM; de Menezes Pacheco Serio PA; de Gouvêa ACRC; Geyer FC; Basso RA; Pasini FS; Del Pilar Esteves Diz M; Brentani MM; Guedes Sampaio Góes JC; Chammas R; Boutros PC; Koike Folgueira MAA
Oncotarget; 2018 Apr; 9(32):22460-22479. PubMed ID: 29854292
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of the MLH1 V384D germline mutation in patients with HER2-positive luminal B breast cancer.
Lee SE; Lee HS; Kim KY; Park JH; Roh H; Park HY; Kim WS
Sci Rep; 2019 Jul; 9(1):10966. PubMed ID: 31358837
[TBL] [Abstract][Full Text] [Related]
3. The genetic landscape of breast carcinomas with neuroendocrine differentiation.
Marchiò C; Geyer FC; Ng CK; Piscuoglio S; De Filippo MR; Cupo M; Schultheis AM; Lim RS; Burke KA; Guerini-Rocco E; Papotti M; Norton L; Sapino A; Weigelt B; Reis-Filho JS
J Pathol; 2017 Feb; 241(3):405-419. PubMed ID: 27925203
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutation profiling in
Kwong A; Cheuk IW; Shin VY; Ho CY; Au CH; Ho DN; Wong EY; Yu SW; Chen J; Chan KK; Ngan HY; Chan TL; Ma ES
Am J Cancer Res; 2020; 10(9):2919-2932. PubMed ID: 33042626
[TBL] [Abstract][Full Text] [Related]
5. Whole-exome sequencing to identify novel somatic mutations in squamous cell lung cancers.
Zheng CX; Gu ZH; Han B; Zhang RX; Pan CM; Xiang Y; Rong XJ; Chen X; Li QY; Wan HY
Int J Oncol; 2013 Sep; 43(3):755-64. PubMed ID: 23799614
[TBL] [Abstract][Full Text] [Related]
6. Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy.
Ellingson MS; Hart SN; Kalari KR; Suman V; Schahl KA; Dockter TJ; Felten SJ; Sinnwell JP; Thompson KJ; Tang X; Vedell PT; Barman P; Sicotte H; Eckel-Passow JE; Northfelt DW; Gray RJ; McLaughlin SA; Moreno-Aspitia A; Ingle JN; Moyer AM; Visscher DW; Jones K; Conners A; McDonough M; Wieben ED; Wang L; Weinshilboum R; Boughey JC; Goetz MP
Breast Cancer Res Treat; 2015 Sep; 153(2):435-43. PubMed ID: 26296701
[TBL] [Abstract][Full Text] [Related]
7. The Genomic Landscape of Male Breast Cancers.
Piscuoglio S; Ng CK; Murray MP; Guerini-Rocco E; Martelotto LG; Geyer FC; Bidard FC; Berman S; Fusco N; Sakr RA; Eberle CA; De Mattos-Arruda L; Macedo GS; Akram M; Baslan T; Hicks JB; King TA; Brogi E; Norton L; Weigelt B; Hudis CA; Reis-Filho JS
Clin Cancer Res; 2016 Aug; 22(16):4045-56. PubMed ID: 26960396
[TBL] [Abstract][Full Text] [Related]
8. Mutational profiling of familial male breast cancers reveals similarities with luminal A female breast cancer with rare TP53 mutations.
Deb S; Wong SQ; Li J; Do H; Weiss J; Byrne D; Chakrabarti A; Bosma T; ; Fellowes A; Dobrovic A; Fox SB
Br J Cancer; 2014 Dec; 111(12):2351-60. PubMed ID: 25490678
[TBL] [Abstract][Full Text] [Related]
9. GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival.
Jiang YZ; Yu KD; Zuo WJ; Peng WT; Shao ZM
Cancer; 2014 May; 120(9):1329-37. PubMed ID: 24477928
[TBL] [Abstract][Full Text] [Related]
10. Exomes of Ductal Luminal Breast Cancer Patients from Southwest Colombia: Gene Mutational Profile and Related Expression Alterations.
Cortes-Urrea C; Bueno-Gutiérrez F; Solarte M; Guevara-Burbano M; Tobar-Tosse F; Vélez-Varela PE; Bonilla JC; Barreto G; Velasco-Medina J; Moreno PA; Rivas JL
Biomolecules; 2020 Apr; 10(5):. PubMed ID: 32365829
[TBL] [Abstract][Full Text] [Related]
11. PALB2 mutations in BRCA1/2-mutation negative breast and ovarian cancer patients from Poland.
Kluska A; Balabas A; Piatkowska M; Czarny K; Paczkowska K; Nowakowska D; Mikula M; Ostrowski J
BMC Med Genomics; 2017 Mar; 10(1):14. PubMed ID: 28279176
[TBL] [Abstract][Full Text] [Related]
12. p53 alteration in morphologically normal/benign breast luminal cells in BRCA carriers with or without history of breast cancer.
Wang X; El-Halaby AA; Zhang H; Yang Q; Laughlin TS; Rothberg PG; Skinner K; Hicks DG
Hum Pathol; 2017 Oct; 68():22-25. PubMed ID: 28438622
[TBL] [Abstract][Full Text] [Related]
13. Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer.
Lin PH; Kuo WH; Huang AC; Lu YS; Lin CH; Kuo SH; Wang MY; Liu CY; Cheng FT; Yeh MH; Li HY; Yang YH; Hsu YH; Fan SC; Li LY; Yu SL; Chang KJ; Chen PL; Ni YH; Huang CS
Oncotarget; 2016 Feb; 7(7):8310-20. PubMed ID: 26824983
[TBL] [Abstract][Full Text] [Related]
14. [Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai].
Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3030-4. PubMed ID: 16324400
[TBL] [Abstract][Full Text] [Related]
15. High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer.
Aceto GM; Solano AR; Neuman MI; Veschi S; Morgano A; Malatesta S; Chacon RD; Pupareli C; Lombardi M; Battista P; Marchetti A; Mariani-Costantini R; Podestà EJ
Breast Cancer Res Treat; 2010 Aug; 122(3):671-83. PubMed ID: 19851859
[TBL] [Abstract][Full Text] [Related]
16. Somatic and Germline Genomic Alterations in Very Young Women with Breast Cancer.
Waks AG; Kim D; Jain E; Snow C; Kirkner GJ; Rosenberg SM; Oh C; Poorvu PD; Ruddy KJ; Tamimi RM; Peppercorn J; Schapira L; Borges VF; Come SE; Brachtel EF; Warner E; Collins LC; Partridge AH; Wagle N
Clin Cancer Res; 2022 Jun; 28(11):2339-2348. PubMed ID: 35101884
[TBL] [Abstract][Full Text] [Related]
17. BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.
Musolino A; Bella MA; Bortesi B; Michiara M; Naldi N; Zanelli P; Capelletti M; Pezzuolo D; Camisa R; Savi M; Neri TM; Ardizzoni A
Breast; 2007 Jun; 16(3):280-92. PubMed ID: 17257844
[TBL] [Abstract][Full Text] [Related]
18. Somatic BRCA1 mutations in clinically sporadic breast cancer with medullary histological features.
Rechsteiner M; Dedes K; Fink D; Pestalozzi B; Sobottka B; Moch H; Wild P; Varga Z
J Cancer Res Clin Oncol; 2018 May; 144(5):865-874. PubMed ID: 29453630
[TBL] [Abstract][Full Text] [Related]
19. Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.
Foo TK; Tischkowitz M; Simhadri S; Boshari T; Zayed N; Burke KA; Berman SH; Blecua P; Riaz N; Huo Y; Ding YC; Neuhausen SL; Weigelt B; Reis-Filho JS; Foulkes WD; Xia B
Oncogene; 2017 Jul; 36(29):4161-4170. PubMed ID: 28319063
[TBL] [Abstract][Full Text] [Related]
20. Mutational Landscape and In-Silico Analysis of
Ahmad H; Ali A; Ali R; Khalil AT; Khan I; Khan MM; Alorini M
ACS Omega; 2023 Nov; 8(45):43318-43331. PubMed ID: 38024667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
